VHL and neoplasm: In the current study, we focused on the discrimination of CCPRCC from other tumor types by applying the well-known immunohistochemical markers supplemented with a molecular analysis that seeks to find chromosomal abberations and VHL abnormalities (including mutations as well as methylation analysis).